Erste Asset Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.15M Buy
8,700
+3,000
+53% +$798K 0.02% 355
2025
Q4
$1.45M Sell
5,700
-12,500
-69% -$2.63M 0.01% 391
2025
Q3
$3.22M Hold
18,200
0.03% 303
2025
Q2
$2.53M Hold
18,200
0.02% 366
2025
Q1
$3.35M Hold
18,200
0.04% 256
2024
Q4
$2.9M Hold
18,200
0.04% 283
2024
Q3
$3.22M Hold
18,200
0.04% 275
2024
Q2
$3.33M Hold
18,200
0.04% 264
2024
Q1
$3.23M Hold
18,200
0.04% 265
2023
Q4
$2.33M Buy
18,200
+12,800
+237% +$1.42M 0.03% 278
2023
Q3
$637K Hold
5,400
0.01% 383
2023
Q2
$625K Hold
5,400
0.01% 399
2023
Q1
$428K Hold
5,400
0.01% 436
2022
Q4
$431K Hold
5,400
0.01% 436
2022
Q3
$381K Hold
5,400
0.01% 449
2022
Q2
$349K Hold
5,400
0.01% 464
2022
Q1
$361K Buy
+5,400
New +$337K 0.01% 463

Other funds holding KRYS